Pharma bro martin shkreli biography

Martin Shkreli (, born March 17, 1983) is an American businessman, former hedge fund manager and convicted fraudster.^[2][3][4][5] He is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, MSMB Healthcare,^[6] co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin, and founder and former CEO of Turing Pharmaceuticals.

Controversy

[change | change source]

In September 2015, Shkreli received widespread criticism when Turing got the manufacturing license for the antiparasitic drug Daraprim and raised its price by a factor of 56 (from $13.50 to $750 per pill), leading him to be referred to as "the most hated man in America" and "pharma bro".^[7][8]

Arrest and conviction

[change | change source]

In December 2015, Shkreli was arrested by the FBI after being indicted on federal charges of securities fraud.

He subsequently as CEO of Turing Pharm